Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07439484 · ClinicalTrials.gov registry record · NA
Individually Tailored, Supervised, Remote Exercise Intervention to Improve Physical Function for Stage I-III Gastroesophageal Cancer Survivors, PRECISE Trial
A NA study, sponsored by Jonsson Comprehensive Cancer Center.
- Not yet
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT07439484 is a NA study that has not yet begun recruiting, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 20 participants.
The verdict
NCT07439484, a NA study, has not yet begun recruiting, sponsored by Jonsson Comprehensive Cancer Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This clinical trial tests an individually tailored, supervised, remote exercise intervention to improve physical function for stage I-III gastroesophageal cancer survivors. Modern treatments for gastroesophageal cancer are effective at treating the cancer but are often aggressive, can be difficult for patients to tolerate, and can lead to significant debilitation and a loss of independence. Exercise is one promising intervention that could improve physical function in patients with gastroesophageal cancer after finishing systemic treatment. Home based exercise interventions in patients with cancer during and after chemotherapy can improve fatigue and function. An individually tailored, supervised, remote exercise intervention may improve physical function for stage I-III gastroesophageal cancer survivors.
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Educational Intervention
- OTHER Electronic Health Record Review
- OTHER Actigraphy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-09-01 |
| Est. Completion | 2028-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07439484
The ClinicalTrials.gov registry entry for NCT07439484 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jonsson Comprehensive Cancer Center, which has 321 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Biospecimen Collection is the first listed.
NCT07439484 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07439484 about?
NCT07439484 is a clinical study titled "Individually Tailored, Supervised, Remote Exercise Intervention to Improve Physical Function for Stage I-III Gastroesophageal Cancer Survivors, PRECISE Trial". This clinical trial tests an individually tailored, supervised, remote exercise intervention to improve physical function for stage I-III gastroesophageal cancer survivors. Modern treatments for gastroesophageal cancer are effective at treating the cancer but are often aggressive, can be difficult f...
What is the current status of trial NCT07439484?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-09-01. Estimated completion is 2028-09-01.
What interventions are being tested in trial NCT07439484?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Educational Intervention (OTHER), Electronic Health Record Review (OTHER), Actigraphy (OTHER).
Who is sponsoring clinical trial NCT07439484?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.